|
|
|
|
|
|
|
The company’s primary research directions include ribose antineoplastics and carbapenem antibiotics. The company has been successful in customizing Meropenem (cas :96036-03-2), Imipenem (cas :64221-86-9) , tebipenem (cas :161715-24-8), Decitabine (cas :2353-33-5), Gemcitabine (cas :95058-81-4), Capecitabine (cas :158798-73-3), Docetaxel (cas: 114977 -28-5), Ubenimex (cas :58970-76-6) and other types of side chains, intermediates, and also in synthesizing bulk drug research samples for domestic and foreign pharmaceutical companies |
|
|
| pregabalin, ubenimex, capecitabine, doranidazole, bivalirudin, bendamustine, aprepitant, anidulafungin, imatinib , cabazitaxel, palonosetron, roflumilast, sarpogrelate |
|
|
| Company : |
HK SIHUI PHARMACY LIITED |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
